Headlands Technologies LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Headlands Technologies LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$27.21 - $39.48 $64,923 - $94,199	2,386 Added 7696.77%	2,417 $69,000
Q4 2023 Feb 02, 2024	SELL	$21.2 - $31.03 $39,262 - $57,467	-1,852 Reduced 98.35%	31 $0
Q3 2023 Nov 09, 2023	SELL	$26.2 - $36.08 $21,274 - $29,296	-812 Reduced 30.13%	1,883 $50,000
Q2 2023 Aug 03, 2023	BUY	$25.16 - $41.38 $67,806 - $111,519	2,695 New	2,695 $96,000

295

92.3M

1.33M

549K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.99B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Headlands Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Headlands Technologies LLC with notifications on news.